Pioneering a New Branch of Medicine
CellSonic Ltd — biophysics technology for chronic disease through Very Intense Pressure Pulse technology. Non-invasive, no side effects, no drugs.
Our Story
We have all at some time been helped by surgery and pharmaceuticals. It may have only been a stitch to close a wound or a pill to block pain but without these long standing medical methods we may not have got to where we are now.
But what if that wound had been infected and turned to gangrene and if that pain had been caused by the early stages of cancer — would we have survived? Most likely we would have died. Traditional medicine struggles with wounds, cancer, psoriasis, periodontal infection and many other common, debilitating diseases.
It is in these areas where surgery and pharmaceuticals fail that CellSonic succeeds. We give you a new branch of medicine. There are no side effects, no risks, it is non-invasive and the costs are low.
The technology is based on the pressure pulses developed forty years ago to pulverise kidney stones. CellSonic has made the machines smaller, weaker, faster and much lower in price. The main advance is the high voltage switching used to make the high pressure pulses.
It is the fast switching of the CellSonic medical machine that makes it unique. The intense pressure pulse it produces kills all infection, increases vascularisation, repairs nerves and stops cancer. No drugs can do all this so efficiently and safely. CellSonic works with the immune system to heal without the risk of collateral damage.

Our Journey
Shockwave technology development begins for lithotripsy
First medical applications beyond kidney stones explored
VIPP (Very Intense Pressure Pulse) technology invented
CellSonic Ltd formally established
First wound healing clinical results published
Cancer and cell voltage research applications pioneered
Sapiens Shield launched for surface sterilisation
CE & ISO 13485:2016 medical device certification achieved
3000+ global CellSonic community across 30+ conditions

Prof. Andrew Hague
President, CellSonic Ltd
Leadership
Professor Andrew Hague is the founder and president of CellSonic Ltd. With decades of experience in engineering and medical technology, he recognised that the principles of lithotripsy — the use of pressure waves to break kidney stones — could be repurposed to treat a vastly wider range of medical conditions.
Under his leadership, CellSonic developed VIPP technology, which uniquely combines three physical forces — pressure waves, light energy, and an electrical field — to stimulate the body's own healing mechanisms. Prof. Hague has championed the concept of biophysics as a "new branch of medicine," complementing surgery and pharmaceuticals.
He has authored numerous articles and papers on cell voltage, cancer biophysics, and regenerative medicine, and has built a global network of practitioners, clinics, and distributors spanning every continent. His vision is a world where effective medical treatment is accessible, affordable, and free from side effects.
Our Global Network
CellSonic works with leading practitioners and researchers worldwide who are advancing pressure pulse medicine.

Dr. Karim Bilal
Clinical Director

Dr. Mahajan
Senior Practitioner

Dr. Dickens
Medical Researcher

Lloyd
Clinical Specialist

Dr. Szadkowski
Orthopaedic Specialist

Dr. Haltiwanger
Cell Voltage Research

Berit
Practitioner

Arthur Brown
Team Member
Awards & Recognition
CellSonic's pioneering work in biophysics has been recognised by leading innovation and research bodies worldwide.

Innovation Awards 2022
CellSonic team at The Innovation Awards ceremony, winning for breakthrough medical technology.

Technology Innovator Awards 2023
Innovation in Business — Technology Innovator of the Year recognition.
International Lifetime Achievement
Asia Research Awards — Best Lifetime Achievement Award for Prof. Andrew Hague in Biophysics.
The Three Branches of Medicine
CellSonic represents a third approach to medicine — working alongside surgery and pharmaceuticals to address conditions they cannot.
Surgery
Effective for structural repairs, removal, and mechanical interventions. Essential but invasive with risks and recovery time.
Pharmaceuticals
Effective for symptom management yet carries side effects and risk of dependency. Essential for many conditions.
CellSonic VIPP
Non-invasive pressure pulse technology. No drugs, no side effects, works with the immune system. Addresses conditions where others fail.
Certifications & Regulatory
CE Marked
European conformity for medical devices
ISO 13485:2016
Quality management for medical devices
ISO 9001:2017
Quality management systems standard
FDA Registered
Registration No. 3017514970
Want to Learn More?
We are not here writing a text book, only an introduction. This site is an invitation to ask questions — and we will reply quickly.

